Wordt geladen...
Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study
BACKGROUND: Aortic stenosis (AS) is the most common primary valvular disease. Currently, there is no pharmacological approach for the medical management of AS. We investigated the effect of osteoporosis therapy with alendronate on hemodynamic progression in patients concurrently affected by AS and o...
Bewaard in:
| Gepubliceerd in: | J Res Med Sci |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer - Medknow
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7554420/ https://ncbi.nlm.nih.gov/pubmed/33088302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jrms.JRMS_408_20 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|